Preliminary scientific studies point out conolidine might inhibit unique ion channels, cutting down neuronal excitability and limiting soreness signals. This mechanism is particularly applicable in neuropathic agony, wherever abnormal signaling results in persistent soreness. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR)